|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00512 GRAND PHARMA
Nominal 
5.240 -0.020 (-0.380%) | 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | |
| Turnover | 6,388,913 | 3.227% | 6,189,196 | 6,047,236 | 5,989,486 | 5,212,581 |
| Cost of Sales | (3,021,240) | 19.127% | (2,536,157) | (2,455,927) | (2,121,049) | (1,952,487) |
| Gross Profit | 3,367,673 | -7.812% | 3,653,039 | 3,591,309 | 3,868,437 | 3,260,094 |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 114,376 | -34.490% | 174,593 | 443,749 | 170,006 | (392,560) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 58,314 | 0.639% | 57,944 | 18,816 | (6,811) | (48,382) | |
| Profit / (Loss) before Taxation | 1,258,081 | -9.103% | 1,384,070 | 1,831,882 | 1,325,697 | 915,700 | |
| Taxation | (189,475) | 4.816% | (180,769) | (244,175) | (268,926) | (217,777) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (7,068) | -30.255% | (10,134) | (29,762) | (27,417) | 12,488 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 1,061,538 | -11.032% | 1,193,167 | 1,557,945 | 1,029,354 | 710,411 | |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | |
| Net Finance Costs / (Income) | 76,756 | -6.389% | 81,995 | 86,121 | 113,233 | 63,213 |
| Depreciation & Amortisation | 349,495 | 18.473% | 295,000 | 249,159 | 191,555 | 172,539 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | 30.310 | -11.036% | 34.070 | 44.410 | 29.120 | 20.160 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 4.862 | -- | 4.833 | 4.428 | 4.071 | 3.827 |
| Remarks: | Real time quote last updated: 28/08/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 1,061,538 |
| %Change | -11.032% |
| EPS / (LPS) | HKD 0.303 |
| NBV Per Share ($) | HKD 4.862 |